Skip to main content
. 2021 Aug 2;41(8):BSR20210866. doi: 10.1042/BSR20210866

Table 3. The responses in the two groups (NSE < 26.1/NSE ≥ 26.1 ng/ml).

Variable Number of all patients (%)
NSE < 26.1 ng/ml NSE ≥ 26.1 ng/ml
Overall 298 (100) 65 (100)
CR 0 (0.0) 0 (0.0)
PR 56 (18.79) 2 (3.08)
SD 81 (27.18) 12 (18.46)
Progressive disease 161 (54.03) 51 (78.46)
ORR 56 (18.79) 2 (3.08)
DCR 137 (45.97) 14 (21.54)